SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/25/24 Selectis Health, Inc. 8-K:5 3/18/24 10:187K M2 Compliance LLC/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 31K 5: R1 Cover HTML 44K 7: XML IDEA XML File -- Filing Summary XML 11K 10: XML XBRL Instance -- form8-k_htm XML 15K 6: EXCEL IDEA Workbook of Financial Report Info XLSX 8K 3: EX-101.LAB XBRL Labels -- gbcs-20240318_lab XML 96K 4: EX-101.PRE XBRL Presentations -- gbcs-20240318_pre XML 63K 2: EX-101.SCH XBRL Schema -- gbcs-20240318 XSD 12K 8: JSON XBRL Instance as JSON Data -- MetaLinks 25± 34K 9: ZIP XBRL Zipped Folder -- 0001493152-24-011175-xbrl Zip 14K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): i March 18, 2024
(Exact Name of Registrant as Specified in its Charter)
i Utah | i 0-15415 | i 87-0340206 | ||
(State or other jurisdiction of incorporation) |
Commission File Number |
(I.R.S. Employer Identification number) |
i 8480 E. Orchard Road, i Ste. 4900, i Greenwood Village, i CO i 80111
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: i (720) i 680-0808
(Former name or former address, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class | Trading Symbol | Name of each exchange on which registered | ||
N/A | N/A | N/A |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. i ☐
ITEM 5.02 | ELECTIONOF DIRECTORS; APPPOINTMENT OF CERTAIN OFFICERS |
Effective March 18, 2024, the Board of Directors of Selectis Health, Inc., a Utah corporation (the “Company”) appointed Adam Desmond to the position of Chief Executive Officer. Previously Mr. Desmond was serving as Interim CEO. Mr. Desmond’s compensation will remain the same.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Selectis Health, Inc. (Registrant) | ||
Dated: March 25, 2024 | /s/ Adam Desmond | |
Adam Desmond, CEO |
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 3/25/24 | 8-K | ||
For Period end: | 3/18/24 | 8-K | ||
List all Filings |